Close
Help




JOURNAL

Clinical Medicine Reviews in Oncology



Is this journal right for my paper?

Ask Editor in Chief
Submit a Paper

Editor in Chief: Garry Walsh

Indexing & Databases: EBSCO Academic Search International, Gale Academic OneFile, Gale Health Reference Centre, Gale InfoTrac Custom Journals

Journal Directories: EBSCO A-Z

Processing Speed: High quality, constructive peer review and rapid editorial decision within an average of four weeks.

ISSN: 1179-2531



Sign up for email alerts to receive notifications of new articles published in Clinical Medicine Reviews in Oncology

Article Search

2015:5

Jaundice in Gall Bladder Cancer – The Yellow Signal
Vinay K. Kapoor
Clinical Medicine Reviews in Oncology 2015:5 1-3
Original research | Published on 15 Nov 2015



2012:4

Current and Emerging Therapies in T-cell Acute Lymphoblastic Leukemia
Chuan-dong Geng
Clinical Medicine Reviews in Oncology 2012:4 1-14
Original research | Published on 09 Jan 2012



2011:3

Current and Emerging Strategies for the Management of Bladder Cancer
Yasuyoshi Miyata and Hideki Sakai
Clinical Medicine Reviews in Oncology 2011:3
Original research | Published on 20 Feb 2011



Pharmacotherapy of Basal Cell Carcinoma, Anogenital Warts, and Actinic Keratoses: Focus on Topical Imiquimod
Caroline Caperton, Martha Viera, Sadegh Amini, Whitney Valins and Brian Berman
Clinical Medicine Reviews in Oncology 2011:3
Original research | Published on 27 Feb 2011



Temsirolimus: Safety and Efficacy in the Treatment of Renal Cell Carcinoma
M. Hammad Ather and Syed M. Nazim
Clinical Medicine Reviews in Oncology 2011:3
Original research | Published on 03 Mar 2011



Treatment of Advanced Hepatocellular Carcinoma: Sorafenib and Beyond
Courtney Gabriel and Weijing Sun
Clinical Medicine Reviews in Oncology 2011:3
Original research | Published on 25 Apr 2011



The Role of Plerixafor in the Management of Non-Hodgkin’s Lymphoma and Hematopoietic Stem Cell Transplantation 
Eleftheria Hatzimichael, Eleni Kapsali, Tim Crook and Mark Tuthill
Clinical Medicine Reviews in Oncology 2011:3
Original research | Published on 03 May 2011



Bevacizumab in Combination with Interferon Alpha in Metastatic Renal Cell Carcinoma: The Emerging Evidence of Its Therapeutic Value
Rodney M. Jamil and David F. McDermott
Clinical Medicine Reviews in Oncology 2011:3
Original research | Published on 05 May 2011



Sunitinib Efficacy in Advanced Pancreatic Neuroendocrine Tumors
Mohamed Abdulla and Emad Shash
Clinical Medicine Reviews in Oncology 2011:3
Original research | Published on 17 May 2011



A Review of the Treatment Options in Recurrent Glioblastoma: Focus on Bevacizumab
Raymund L. Yong and John K. Park
Clinical Medicine Reviews in Oncology 2011:3
Original research | Published on 19 May 2011



Management of Ovarian Cancer and Soft Tissue Sarcoma: Focus on Trabectedin
Karen Cowden Dahl, Teresa W. Chan, Bander Balkhi and Reema Zeineldin
Clinical Medicine Reviews in Oncology 2011:3 93-105
Original research | Published on 24 Aug 2011 | Highly accessed (previous month)



Denosumab as Bone Modifying Therapy in Solid Tumors
Joanne E. Mortimer and Sumanta Kumar Pal
Clinical Medicine Reviews in Oncology 2011:3 107-113
Original research | Published on 20 Oct 2011



2010:2

Colorectal Cancer: Focus on Capecitabine
Pasquale Comella, Antonio Avallone, Biagio Pecori and Paolo Delrio

Clinical Medicine Reviews in Oncology 2010:2


Original research | Published on 27 Jan 2010

The Treatment of Advanced Breast Cancer: Focus on Fulvestrant
Rajul Kothari and Peter Argenta
Clinical Medicine Reviews in Oncology 2010:2
Original research | Published on 16 Feb 2010



Pharmacotherapy of B-cell non-Hodgkin Lymphoma:  Focus on Rituximab
Nozomi Niitsu
Clinical Medicine Reviews in Oncology 2010:2

Original research | Published on 17 Feb 2010



Metastatic Renal Cancer: What Role for Everolimus?
Franck A. Belibi and Charles L. Edelstein
Clinical Medicine Reviews in Oncology 2010:2
Original research | Published on 18 Feb 2010



Altered Gene Expression in Human Hepatoma (HepG2) Cells Exposed to Low-Level Sodium Arsenite
John Nordlee, Steven Petrinac, Adnan Ali and Lalita Bharadwaj
Clinical Medicine Reviews in Oncology 2010:2
Original research | Published on 22 Feb 2010



Chemotherapy-induced Nausea and Vomiting: Pharmacotherapy Update and Trends for Better Control
Michael E. Trigg
Clinical Medicine Reviews in Oncology 2010:2
Original research | Published on 17 Mar 2010



The Role of Imatinib in Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia
Amber Fullmer, Hagop Kantarjian and Elias Jabbour

Clinical Medicine Reviews in Oncology 2010:2
Original research | Published on 19 Mar 2010



Anastrozole Versus Exemestane in Patients with Postmenopausal Breast Cancer and Visceral Metastases
Jasgit C. Sachdev, Andrew M. Schreiber and Mohammad Jahanzeb
Clinical Medicine Reviews in Oncology 2010:2
Original research | Published on 31 Mar 2010



Hormone Receptor Positive Early Breast Cancer: What Role for Aromatase Inhibitors?
Alice Dewdney and Sarah Needleman

Clinical Medicine Reviews in Oncology 2010:2 


Original research | Published on 26 Mar 2010

Everolimus: Emerging Evidence of its Therapeutic Impact in Patients with Advanced Renal Cell Carcinoma
Daniel C. Cho and Michael B. Atkins
Clinical Medicine Reviews in Oncology 2010:2
Original research | Published on 31 Mar 2010



Metastatic Colorectal Cancer: Focus on Panitumumab
S. Lindsey Davis and Antonio Jimeno
Clinical Medicine Reviews in Oncology 2010:2
Original research | Published on 30 Mar 2010



Current and Emerging Pharmacotherapies of Breakthrough Pain in Cancer
Jeffrey B. Rubins
Clinical Medicine Reviews in Oncology 2010:2
Original research | Published on 19 Apr 2010



Capecitabine Associated Hand-Foot Syndrome: A Review
Esther Uña Cidón
Clinical Medicine Reviews in Oncology 2010:2
Original research | Published on 21 Apr 2010



Imiquimod 5% Cream: A Review of Its Safety and Efficacy in the Management of Superficial Basal Cell Carcinoma
Lance E. Davis, Katherine Fiala and David F. Butler
Clinical Medicine Reviews in Oncology 2010:2
Original research | Published on 28 Apr 2010



The Pharmacology of Trastuzumab and Its Use in Breast Cancer
Nicola Cresti and David Jamieson
Clinical Medicine Reviews in Oncology 2010:2
Original research | Published on 03 May 2010



A Review of Dutasteride as Monotherapy in Benign Prostatic Hyperplasia
Greg Trottier, Nathan Lawrentschuk and Neil E. Fleshner
Clinical Medicine Reviews in Oncology 2010:2
Original research | Published on 05 May 2010



Metastatic Breast Cancer: Focus on Capecitabine
Mrinal Dutia and Helen K. Chew
Clinical Medicine Reviews in Oncology 2010:2
Original research | Published on 11 May 2010



Degarelix in the Treatment of Prostate Cancer
Barbara Ercole and Ian M. Thompson Jr
Clinical Medicine Reviews in Oncology 2010:2
Original research | Published on 13 May 2010



Platinum and Pemetrexed Combination in Advanced Solid Tumors
G. Finocchiaro, P.A. Zucali and A. Santoro
Clinical Medicine Reviews in Oncology 2010:2
Original research | Published on 17 May 2010



Review of Palonosetron in the Prevention of Chemotherapy-Induced Nausea and Vomiting
Mitsue Saito
Clinical Medicine Reviews in Oncology 2010:2
Original research | Published on 18 May 2010



Cetuximab: The Emerging Evidence of its Therapeutic Value in Squamous Cell Carcinoma of the Head and Neck
Ayodele Ayoola, Yixing Jiang and Chandra P. Belani
Clinical Medicine Reviews in Oncology 2010:2
Original research | Published on 19 May 2010



Targeted Therapy for Locally Advanced or Metastatic Non-Small Cell Lung Cancer—Patient Selection Changes the Fate of Gefitinib
Susanne Rogers and Imogen Locke
Clinical Medicine Reviews in Oncology 2010:2
Original research | Published on 24 May 2010



Albumin-Bound Paclitaxel in the Treatment of Metastatic Breast Cancer
Alicia Soria Lovelle and Miguel Martín
Clinical Medicine Reviews in Oncology 2010:2
Original research | Published on 21 Jul 2010



Maintenance Therapy of Patients with Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer—Role of Pemetrexed
Michael Kreuter and Niels Reinmuth
Clinical Medicine Reviews in Oncology 2010:2
Original research | Published on 23 Sep 2010



Gemcitabine in Non-Small Cell Lung Cancer (NSCLC): The Evidence of its Therapeutic Value in Molecular Age
M.J. Villanueva-Silva, J. Casal-Rubio, C. Grande-Ventura and G. Huidobro-Vence
Clinical Medicine Reviews in Oncology 2010:2
Original research | Published on 25 Oct 2010



Comparative Review of Denosumab Versus Zoledronic Acid for the Reduction or Delay of Serious Complications Associated with Bone Metastases of Breast Cancer
Jun Iwamoto, Yoshihiro Sato, Tsuyoshi Takeda and Hideo Matsumoto
Clinical Medicine Reviews in Oncology 2010:2
Original research | Published on 18 Oct 2010



Bortezomib: Safety and Efficacy in the Treatment of Multiple Myeloma
Tom Martin and Jeffrey Wolf
Clinical Medicine Reviews in Oncology 2010:2
Original research | Published on 01 Nov 2010



Bendamustine in the Management of Non-Hodgkins Lymphoma
Christian Saure, Guido Kobbe, Rainer Haas and Roland Fenk
Clinical Medicine Reviews in Oncology 2010:2
Original research | Published on 02 Nov 2010



First-Line Treatment of Metastatic Colorectal Cancer: Focus on Cetuximab in Combination with Chemotherapy
Allison L. Balko, Esther P. Black and Justin M. Balko
Clinical Medicine Reviews in Oncology 2010:2
Original research | Published on 05 Dec 2010



2009:1

Introductory Editorial
Garry Walsh
Clinical Medicine Reviews in Oncology 2009:1 
Original research | Published on 09 Jul 2009





  • Efficient Processing: 4 Weeks Average to First Editorial Decision
  • Fair & Independent Expert Peer Review
  • High Visibility & Extensive Database Coverage
Services for Authors
What Your Colleagues Say About Clinical Medicine Reviews in Oncology
The process of submitting the paper was smooth with little time required on the author's behalf. Reviews were prompt and the process of addressing reviewer comments was very streamlined. All correspondence with the editorial office was extremely professional with immediate responses. This is one of the few journals asking for feedback on their submission process.
Dr Greg Trottier, MD, PhD, FRCSC (University of Toronto, Toronto, Ontario, Canada)
More Testimonials

Quick Links


New article and journal news notification services
Email Alerts RSS Feeds
Facebook Google+ Twitter
Pinterest Tumblr YouTube